Phase 3 Artery Disease Clinical Trials
20 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–20 of 20 trials
Recruiting
Phase 2Phase 3
Canagliflozin Targeting Vascular Inflammation
Coronary Artery DiseaseDiabetes Type 2
Ottawa Heart Institute Research Corporation24 enrolled1 locationNCT05427084
Recruiting
Phase 3
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
Coronary Artery DiseaseAcute Myocardial Infarction (AMI)Coronary Atherosclerosis of Native Coronary Artery
ECRI bv332 enrolled1 locationNCT07276282
Recruiting
Phase 3
Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)
Coronary Artery Disease (CAD)
Sinotau Pharmaceutical Group395 enrolled5 locationsNCT07439133
Recruiting
Phase 3
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
Coronary Artery Disease
MedTrace Pharma A/S215 enrolled14 locationsNCT05134012
Recruiting
Phase 3
Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)
Chronic Coronary SyndromeStable Coronary Artery Disease CAD
Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.1,703 enrolled18 locationsNCT07195149
Recruiting
Phase 3
Perioperative Argon Inhalation to Improve Neurocognitive Recovery After Carotid Surgery
Carotid Artery DiseaseCarotid Artery Stenoses
Negovsky Reanimatology Research Institute100 enrolled1 locationNCT07200180
Not Yet Recruiting
Phase 3Phase 4
COMparative Pharmacotherapy And peRsonalised stratEgy in the management of Coronary Microvascular Dysfunction double blind randomised controlled Trial - Part 1
Angina with non obstructive coronary artery disease
Sydney Local Health District130 enrolled2 locationsACTRN12625001179426
Not Yet Recruiting
Phase 3Phase 4
COMparative Pharmacotherapy And peRsonalised stratEgy in the management of Coronary Microvascular Dysfunction double blind randomised controlled Trial - Part II
Angina with non obstructive coronary artery disease
Sydney Local Health District130 enrolled2 locationsACTRN12625001174471
Not Yet Recruiting
Phase 3
PDE-5 inhibition in Ischaemia with Non-Obstructive Coronary Arteries: a double-blinded, randomised, placebo-controlled trial (PERTINENT)
IschaemiaNon obstructive coronary artery disease
Sydney Local Health District30 enrolled1 locationACTRN12625001161415
Recruiting
Phase 3
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
Coronary Artery Disease
Weill Medical College of Cornell University600 enrolled18 locationsNCT06399705
Recruiting
Phase 3
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
Coronary Artery Disease
Weill Medical College of Cornell University600 enrolled18 locationsNCT06399692
Recruiting
Phase 3
Improving Mobility After Revascularization in Peripheral Artery Disease
intermittent claudicationMobility LimitationPeripheral Artery Disease+2 more
Northwestern University386 enrolled7 locationsNCT06686121
Recruiting
Phase 3
Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
Peripheral Artery DiseaseCritical Limb Ischemia
Mercator MedSystems, Inc.250 enrolled2 locationsNCT04433572
Recruiting
Phase 3
A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
Coronary Artery DiseaseLipidemiaPlaque, Atherosclerotic
NewAmsterdam Pharma300 enrolled1 locationNCT06305559
Recruiting
Phase 3
Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia
Atrial Fibrillation (Paroxysmal)Coronary Artery Disease Without Residual Ischemia
Hippocration General Hospital80 enrolled3 locationsNCT05549752
Recruiting
Phase 3
Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy
Coronary Artery Disease
iVascular S.L.U.2,312 enrolled39 locationsNCT05952206
Recruiting
Phase 3
The COCOA-PAD II Trial
Peripheral Artery Disease
Northwestern University190 enrolled3 locationsNCT04794530
Recruiting
Phase 3
Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
Coronary Artery Disease
AZ Sint-Jan AV2,770 enrolled19 locationsNCT06095765
Recruiting
Phase 3
SAPT Versus DAPT in Incomplete Revascularization After CABG
Coronary Artery Disease
Campus Bio-Medico University800 enrolled1 locationNCT03789916
Recruiting
Phase 2Phase 3
LoDoCo - VRIC Low Dose Colchicine in stable coronary artery disease, Vascular Reactivity and the Inflammatory Cascade.
Coronary Artery Disease
Pfizer Cardiovascular Lipid Research Grant40 enrolled1 locationACTRN12610000397011